GlassScriptPhysician profile
Amanda P Galdi
NPI 1649892340
$13,715.02
in general payments reported to CMS, 2019-2025
21 companies · $1,304 in 2025
The $1,304 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,307 · 2023: $6,225 · 2024: $1,879 · 2025: $1,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,156 · Travel and Lodging: $4,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,155.99 |
| Travel and Lodging | $4,251.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $7,529.35 | 2022-2025 | Venclose Maven Catheter |
| Boston Scientific Corporation | $2,360.37 | 2022-2025 | Varithena Administration Pack, Watchman, V-14 Control Wire |
| Astrazeneca Pharmaceuticals LP | $744.86 | 2022-2024 | Farxiga, Wainua, Lokelma |
| Janssen Pharmaceuticals, INC | $622.00 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $561.90 | 2022-2024 | Verquvo |
| Shockwave Medical, INC | $505.15 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $300.00 | 2022-2025 | Venaseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.75 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $179.31 | 2023-2025 | |
| Galderma Laboratories, L.P. | $123.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.22 | 2022-2024 | |
| Amgen INC. | $95.46 | 2023-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $86.89 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Revance Therapeutics, INC. | $72.28 | 2024 | Daxxify |
| Amarin Pharma, INC. | $70.65 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.61 | 2023 | Jardiance |
| Esperion Therapeutics, INC. | $29.26 | 2022-2025 | Nexletol |
| Novo Nordisk INC | $25.60 | 2025 | Wegovy |
| Philips North America LLC | $22.80 | 2025 | Extended Holter |
| E.R. Squibb & Sons, L.L.C. | $16.66 | 2024 | Eliquis |
| Pfizer INC. | $14.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Galdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.